Skip to main content
. Author manuscript; available in PMC: 2013 Mar 27.
Published in final edited form as: J Alzheimers Dis. 2012;31(2):335–341. doi: 10.3233/JAD-2012-120508

Figure 4.

Figure 4

The CSF Aβ1-15/16:Aβx-40 ratio as a function of time for placebos and after administration of 100 mg, 140 mg and 280 mg of the γ-secretase inhibitor semagacestat. Friedman’s test was used for calculating p-values. The error bars represent standard errors of the mean.